Epstein–Barr virus (EBV) is consistently detected in nasopharyngeal carcinoma (NPC) from
regions of high and low incidence. EBV DNA within the tumor is homogeneous with regard …

Abstract The Epstein-Barr virus latent membrane protein (LMP) 1 is a versatile protein that
has profound effects on target cells through its effect on constitutive cellular proteins, eg …

The Epstein–Barr virus (EBV) latent membrane protein 1 (LMP1) is expressed in multiple
human malignancies and has potent effects on cell growth. It has been detected in …

Background The Epstein–Barr virus (EBV) is consistently detected in patients with
nasopharyngeal carcinoma. To determine whether EBV infection is an early, initiating event …

The pathogenic lymphocryptovirus Epstein–Barr virus (EBV) is shown to express at least 17
distinct microRNAs (miRNAs) in latently infected cells. These are arranged in two clusters …

Epstein-Barr virus (EBV) genome-positive nasopharyngeal carcinomas (NPCs) regularly
express the virus-coded nuclear antigen EBNA1, but not other EBNAs, and a subset of …

We have developed an approach to identify microRNAs (miRNAs) that is based on
bioinformatics and array-based technologies, without the use of cDNA cloning. The …

Nasopharyngeal carcinoma (NPC) samples of distinct histological types, including
squamous cell carcinoma (WHO type 1), nonkeratinizing carcinoma (WHO type 2), and …

Epstein-Barr virus (EBV) is associated with a number of different human tumors and appears
to play different pathogenetic roles in each case. Thus, immunoblastic B cell lymphomas of …

Epstein-Barr virus (EBV) can display different forms of latent infection in B-cell lines in vitro;
however, the types of infection normally established by the virus in vivo remain largely …